Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
Tickers HOOK NEWS RHHBY RPTX
Tags Biotech Health Care Market News
From Benzinga
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.
Tickers HSBC NVS RHHBY SHEL
Tags SHEL Market News HSBC
From Motley Fool
Why Roche Holdings Stock Popped Today
Tickers LLY RHHBY
Tags Market News LLY Recent Press Releases
From Motley Fool
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
Tickers RHHBY RXRX
Tags Market News RXRX Recent Press Releases
From Motley Fool
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data
Tickers ALNY NEWS RHHBY
Tags Benzinga Trading Ideas Analyst Ratings
From Benzinga
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
Tickers LLY REGN RHHBY
Tags Stocks to Buy Market News NYSE:LLY,NASDAQ:REGN,OTCMKTS:RHHBY
From InvestorPlace
Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?
Tickers ARGX JNJ NEWS RHHBY
Tags Health Care Large Cap Biotech
From Benzinga
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Tickers LZAGF LZAGY NEWS RHHBY
Tags M&A LZAGF General
From Benzinga
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
Tickers BGNE NEWS NVS RHHBY
Tags General RHHBY NVS
From Benzinga
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
Tickers ASIA ASML AZN GSK
Tags Biotech Economics Tech
From Benzinga
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
Tickers ABBV BGNE GILD NEWS
Tags Market News GILD FDA
From Benzinga
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges
Tickers ALNY NEWS RHHBY
Tags Reiteration Analyst Color Expert Ideas
From Benzinga
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
Tickers ASML AZN GSK LRLCY
Tags GSK RHHBY Stories That Matter
From Benzinga
This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food Allergies
Tickers NEWS NVS RHHBY
Tags Market News Stories That Matter Benzinga
From Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
Tickers AZN GLAXF LRLCY LVMUY
Tags LVMUY ASMLY RHHBY
From InvestorPlace
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
Tickers NEWS RHHBY SRPT
Tags SRPT Large Cap Biotech
From Benzinga
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
Tickers GLUE NEWS RHHBY
Tags Health Care Equities Biotech
From Benzinga
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
Tickers HOOK NEWS RHHBY RPTX
Tags Stories That Matter RHHBY General
From Benzinga
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
Tickers GILD HOOK MRK NEWS
Tags why it is moving RHHBY General
From Benzinga
Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe
Tickers HALO RHHBY
Tags why it's moving Briefs General
From Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
Tickers MRK NEWS RHHBY
Tags RHHBY General News
From Benzinga
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
Tickers AMGN AMZN COR GOOGL
Tags Health Care healthcare MDT
From Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
Tickers DXCM RHHBY SRPT
Tags Market News DXCM SRPT
From Motley Fool
Why Is LumiraDx (LMDX) Stock Down 13% Today?
Tickers CLRB HARP LMDX RHHBY
Tags RHHBY HARP CLRB
From InvestorPlace
3 Great Foreign Companies to Invest in Right Now
Tickers ASML RHHBY TEAM
Tags Market News ASML Recent Press Releases
From Motley Fool
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
Tickers LMDX NEWS RHHBF RHHBY
Tags News Briefs LMDX
From Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
Tickers AZN LLY NVO PFE
Tags RHHBY Recent Press Releases AZN
From Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Tickers CALT MCK NVS RHHBY
Tags MCK Expert Ideas RHHBY
From Benzinga
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
Tickers NVDA RHHBY
Tags Market News NVDA Recent Press Releases
From Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
Tickers IPO IPOS NVO RHHBY
Tags NVO Benzinga Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.